SHARPIN and polyglucosan body myopathy: Moreover, our observation that biallelic mutation of A18P in the LTM of HOIL-1L causes polyglucosan body myopathy by drastically reducing the amount of LUBAC highlights the pathophysiological significance of the LTM-mediated HOIL-1L-SHARPIN heterodimerization (Figures 5D–5H).